Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2009-09-28
Original SEC Filing: Click here

---

Webplus: SVA/20090928/6-K/2_EX-99.1/000.htm SEC Original: sinovacexh99_1.htm
Sinovac Obtains Production License for H1N1 Vaccine BEIJING, Sept. 3 /PRNewswire-Asia/ — Sinovac Biotech Ltd. (NYSE: SVA), a leading provider of biopharmaceutical products in China, announced today that the State Food and Drug Administration (SFDA) has approved the registration application for PANFLU.1, Sinovac’s H1N1 vaccine, and has issued Sinovac a production license for this vaccine. Following top-line results which showed

---

---

Webplus: SVA/20090928/6-K/1/000.htm SEC Original: sinovac6k090309.htm
FORM 6-K __________ __________ SINOVAC BIOTECH LTD. 39 Shangdi Xi Road Haidian District Beijing 100085, People’s Republic of China X Form 20-F X Yes _______ No N/A 82- SINOVAC BIOTECH LTD. Form 6-K TABLE OF CONTENTS Page 3 4

---

Company Information:

Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2009-09-28CIK: 0001084201, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
39 SHANGDI XI ROAD
BEIJING 100085